The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galena Biopharma Inc

Nasdaq: GALE(*D)
Last

(U.S.) $0.34

Today's change0.00 0.00%
Updated August 23 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Galena Biopharma Inc

Nasdaq: GALE(*D)
Last

(U.S.) $0.34

Today's change0.00 0.00%
Updated August 23 4:00 PM -4GMT. Delayed by at least 15 minutes.

Galena Biopharma Inc closed at (U.S.)$0.34.

Over the last five days, shares have lost 4.90% and are down 82.50% for the last year to date. This security has underperformed the S&P 500 by 107.98% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $0.34
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.34 / (U.S.) $0.68
  • YTD % change-82.50%
  • Volume0
  • Average volume (10-day)737,471
  • Average volume (1-month)687,106
  • Average volume (3-month)629,064
  • 52-week range(U.S.) $0.26 to (U.S.) $9.10
  • Beta1.89
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.86
Updated August 23 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense6587
Selling / general / administrative3333
Research & development2254
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1010
Other operating expenses, total--------
Operating income-6-5-8-7
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-7-2-2-4
Income after tax-7-2-2-4
Income tax, total----0--
Net income-8-12-6-7
Total adjustments to net income--------
Net income before extra. items-7-2-2-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-7-2-2-4
Inc. avail. to common incl. extra. items-8-12-6-7
Diluted net income-8-12-6-7
Dilution adjustment--------
Diluted weighted average shares37261110
Diluted EPS excluding extraordinary itemsvalue per share-0.19-0.09-0.17-0.41
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.15-0.08-0.11-0.40